Upadacitinib for Refractory Behcet's Syndrome: A Multi-center, Prospective, Open-label, Pilot Study

被引：0
|
作者：
Xia, Weiyi [1 ]
Li, Jiachen [1 ]
Liu, Tian [1 ]
Li, Yuhui [2 ]
机构：
[1] Peking Univ, Peoples Hosp, Beijing, Peoples R China
[2] Peking Univ, Beijing, Peoples R China
来源：
ARTHRITIS & RHEUMATOLOGY | 2024年 / 76卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2515
引用
收藏
页码：5121 / 5122
页数：2
相关论文
共 50 条
  • [31] Azathioprine in refractory sprue:: Results from a prospective, open-label study
    Mauriño, E
    Niveloni, S
    Cherñavsky, A
    Pedreira, S
    Mazure, R
    Vazquez, H
    Reyes, H
    Fiorini, A
    Smecuol, E
    Cabanne, A
    Capucchio, M
    Kogan, Z
    Bai, JC
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2002, 97 (10): : 2595 - 2602
  • [32] Extracorporeal Photopheresis for the Treatment of Refractory Crohn's Disease: Results of an Open-label Pilot Study
    Abreu, Maria T.
    von Tirpitz, Christian
    Hardi, Robert
    Kaatz, Martin
    Van Assche, Gert
    Rutgeerts, Paul
    Bisaccia, Emil
    Goerdt, Sergi
    Hanauer, Stephen
    Knobler, Robert
    Mannon, Peter
    Mayer, Lloyd
    Ochsenkuhn, Thomas
    Sandborn, William J.
    Parenti, Dennis
    Lee, Kevin
    Reinisch, Walter
    INFLAMMATORY BOWEL DISEASES, 2009, 15 (06) : 829 - 836
  • [33] A pilot open-label study of the efficacy of subanesthetic isomeric s(+)-ketamine in refractory CRPS patients
    Kiefer, Ralph-Thomas
    Rohr, Peter
    Ploppa, Annette
    Nohe, Boris
    Dieterich, Hans-Juergen
    Grothusen, John
    Altemeyer, Karl-Heinz
    Unertl, Klaus
    Schwartzman, Robert J.
    PAIN MEDICINE, 2008, 9 (01) : 44 - 54
  • [34] Correspondence on 'A pilot study of tofacitinib for refractory Behcet's syndrome'
    Zou, Jun
    Lin, Chen-Hong
    Wang, Yan
    Shen, Yan
    Guan, Jian-Long
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 (04)
  • [35] Two-Step Skincare Regimen Addressing Aging in Three Unique Geographic Locations: A Prospective, Multi-Center, Open-Label Study
    Cohen, Joel L.
    Palm, Melanie
    Biesman, Brian
    Young, Morgann
    Kononov, Tatiana
    Zahr, Alisar S.
    JOURNAL OF DRUGS IN DERMATOLOGY, 2023, 22 (01) : 16 - 22
  • [36] Extension study to the open-label, multi-center, expanded access study of everolimus in patients with advanced neuroendocrine tumors
    Doerffel, Y.
    Kullmann, F.
    Lammert, F.
    Quietzsch, D.
    Schoefl, C.
    Schuppert, F.
    Weber, M.
    Baum, V.
    Berndt, I.
    Weiss, C.
    Lahner, H.
    ONCOLOGY RESEARCH AND TREATMENT, 2017, 40 : 237 - +
  • [37] A multi-center open-label, steady state study to evaluate the pharmacokinetics (PK) of benazepril in pediatric subjects
    Robinson, RF
    Nwose, O
    Hall, D
    Daley, W
    Mahan, JD
    PEDIATRIC RESEARCH, 2004, 55 (04) : 572A - 572A
  • [38] A prospective open-label study of aripiprazole in fragile X syndrome
    Erickson, Craig A.
    Stigler, Kimberly A.
    Wink, Logan K.
    Mullett, Jennifer E.
    Kohn, Arlene
    Posey, David J.
    McDougle, Christopher J.
    PSYCHOPHARMACOLOGY, 2011, 216 (01) : 85 - 90
  • [39] A prospective open-label study of aripiprazole in fragile X syndrome
    Craig A. Erickson
    Kimberly A. Stigler
    Logan K. Wink
    Jennifer E. Mullett
    Arlene Kohn
    David J. Posey
    Christopher J. McDougle
    Psychopharmacology, 2011, 216 : 85 - 90
  • [40] A prospective, open-label study of rituximab for remission induction in patients with refractory Wegener's granulomatosis
    Keogh, KA
    Fervenza, FC
    Ytterberg, SR
    Specks, U
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2005, 20 : V187 - V187
12345